Report ID: SQMIG35J2089
Report ID:
SQMIG35J2089 |
Region:
Global |
Published Date: July, 2036
Pages:
242
|
Tables:
65 |
Figures:
75
Global Amyotrophic Lateral Sclerosis Treatment Market size was valued at USD 662.30 million in 2022 and is poised to grow from USD 704.02 million in 2023 to USD 1147.77 million by 2031, growing at a CAGR of 6.3% in the forecast period (2024-2031).
Amyotrophic lateral sclerosis (ALS), also have different names such as Charcot diseases, Lou Gehrig diseases, Motor neuron diseases. ALS is a progressive neurodegenerative disorder that damage the nerve cell in central nervous system responsible for controlling the voluntary muscles. Some of the common symptoms include muscle twitching, stiff muscles, and weakness due to a decrease in the size of muscles of the legs or arms. Around half of the people suffering from ALS may lose the ability to swallow, breathe, speak, walk, and use their hand.
According to the National Institute of Neurological Disorders and Stroke (NINDS), following gradual paralysis, patients with ALS often die from respiratory failure within 3-5 years. It also states that between the two types of ALS, the sporadic type is the most common form, accounting for 90-95% of all cases in the U.S. while the familial type accounts for the rest. Familial ALS (FALS) is hereditary, where there is a 50% chance of inheriting the genetic mutation for each offspring and eventually developing the disorder. In 25-40% of the people suffering from familial ALS, the defect is most commonly found in the C9ORF72 gene. Mutation in this gene also leads to a condition known as frontotemporal dementia (FTD), which may develop along with ALS as comorbidity referred to as ALS-FTD.
Although there is no cure for ALS, treatments such as medications and stem cell therapies can help in the management of the symptoms, prevention of unnecessary complications and slow down the disease progression. These factors are expected to further drive the global amyotrophic lateral sclerosis treatment market growth.
US Amyotrophic Lateral Sclerosis Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2089